• Foretinib (GSK1363089) Assay Workflows

  2026-09-05

  Build more informative cancer assays with Foretinib (GSK1363089), an ATP-competitive multikinase inhibitor suited to proliferation, motility, invasion, and metastasis research. This guide connects dose design with the crucial distinction between reduced growth and true cell killing, helping researchers select stronger endpoints and troubleshoot inconsistent responses.

• CNO and the Visual–Entorhinal Circuit

  2026-09-05

  A translational framework for using Clozapine N-oxide and DREADDs to test how visual cortical inputs shape medial entorhinal circuitry, spatial coding, and navigation.

• Brain-to-Spinal Control of Mechanical Allodynia

  2026-09-04

  Huo et al. identify a contralateral lPBN–hypothalamus–spinal dorsal horn pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Their causal circuit experiments show how hypothalamic dynorphin and spinal kappa-opioid receptor signaling can restrain bilateral pain hypersensitivity after nerve injury or capsaicin exposure.

• Ibotenic Acid: NMDA Receptor Agonist Guide

  2026-09-04

  Ibotenic acid is an NMDA receptor agonist and metabotropic glutamate receptor agonist used as a neuroscience research tool. Its mouse toxicity is dose- and time-dependent, so product specifications and published exposure findings must be separated from experimental dosing decisions.

• AKT Inhibitors: Molecular and Pharmacologic Insights

  2026-09-03

  This study systematically distinguishes ATP-competitive and allosteric AKT inhibitors using biochemical, cellular, structural, and phosphoproteomic approaches. Its findings show that inhibitor class, AKT isoform, and mutation context can shape drug sensitivity and reveal combination-treatment opportunities in cancer research.

• Ibotenic Acid Toxicity in Mice: Dose and Time Effects

  2026-09-02

  A 2026 study in Toxin Reviews provides a systematic murine assessment of ibotenic acid toxicity across dose and time, linking acute behavioral changes with biochemical disruption, early c-fos activation, and reduced Nissl bodies at higher exposure. The work helps distinguish reversible early responses from markers of neuronal injury and offers a clearer toxicological framework for controlled neuroscience studies.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-09-02

  The Aconitase Activity Colorimetric Assay Kit provides a rapid, plate-based way to connect TCA-cycle function with oxidative injury in cell and tissue samples. Its strongest use is as a complementary metabolic readout alongside CD8+ T-cell activation, PKM splicing, and antitumor-immunity studies—not as a replacement for direct glycolysis or transcript analysis.

• JNK-IN-7 for Reliable Apoptosis Assays

  2026-09-01

  Learn how JNK-IN-7 (SKU A3519) can help researchers separate JNK-dependent signaling from nonspecific cytotoxicity in viability, apoptosis, and innate immune assays. This scenario-based guide covers assay design, formulation, interpretation, and practical vendor-selection criteria.

• Temafloxacin Workflows for Antibacterial Research

  2026-09-01

  Build reproducible MIC, respiratory-pathogen, and intracellular assay workflows with Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent. This guide connects reference-study potency data with practical dilution, cell-based testing, troubleshooting, and comparative assay design.

• MK-8745: Aurora A Inhibitor Workflows

  2026-08-31

  MK-8745 converts selective Aurora A inhibition into practical assays for mitotic arrest, tetraploidy, and apoptosis. This guide connects retinoblastoma target biology with reproducible cell-based, lymphoma, and xenograft-oriented workflows while emphasizing solvent handling and phenotype validation.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-31

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use with rabbit primary antibodies and should not be treated as a diagnostic reagent or assumed to be suitable for live-cell applications because the supplied formulation contains sodium azide.

• Biomimetic Nanoplatform for Metastatic TNBC

  2026-08-30

  The ACS Nano study developed a biomimetic nanoplatform that combines photothermal tumor ablation with tumor vaccination and immune-checkpoint modulation. Its staged, tumor-responsive design improved primary tumor targeting and generated immune effects intended to limit recurrence and metastasis in preclinical triple-negative breast cancer models.

• BCL-XL Inhibition: From Apoptotic Priming to Translation

  2026-08-29

  A mechanistic and strategic guide to using the BCL-XL inhibitor A-1155463 in glioblastoma and broader cancer research, with emphasis on apoptotic priming, model selection, platelet pharmacodynamics, and translational decision-making.

• MEK Inhibition Rewires T-Cell Responses After Radiotherapy

  2026-08-28

  The 2025 Frontiers in Immunology study identifies a cGAS–STING–CXCL10 pathway through which MEK inhibition improves T-cell recruitment and function after radiotherapy in KRAS-mutant lung cancer models. Its findings connect impaired DNA repair with innate immune activation and suggest that combining MEK inhibition with lower-dose radiotherapy merits further preclinical evaluation.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-28

  The reference study shows that puerarin enhances the osteogenic differentiation of rat dental follicle cells while increasing nitric oxide, cGMP, and osteogenic marker expression. Pharmacological inhibition with L-NMMA reversed these effects, supporting a functional role for nitric oxide pathway activation in periodontal regeneration research.

7939 records 1/530 page Next 12345 下5页 Last page